| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/24/2012 | US8101793 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/24/2012 | US8101781 Process for the preparation of highly optical pure carvedilol |
| 01/24/2012 | US8101775 Indole derivatives as S1P1 Receptor |
| 01/24/2012 | US8101749 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 01/24/2012 | US8101649 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 01/24/2012 | US8101648 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 01/24/2012 | US8101646 Amorphous form of an L-arginine salt of perindopril and processes for preparation thereof |
| 01/24/2012 | CA2621404C Novel heterobicyclic derivatives |
| 01/24/2012 | CA2511582C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 01/19/2012 | WO2012009134A1 Crth2 modulators |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012008281A1 Light emitting element |
| 01/19/2012 | WO2012007453A1 Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol |
| 01/19/2012 | US20120016000 Method to assay phospholipid and triglyceride transfer activity of microsomal triglyceride transfer protein |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015807 Trifluromethoxyphenyl-Substituted Tetramic Acid Derivatives Pesticides and/or Herbicides |
| 01/19/2012 | US20120013247 Dendrimer and organic light-emitting device using the same |
| 01/19/2012 | US20120012832 Aromatic amine derivative and organic electroluminescent element using same |
| 01/19/2012 | DE102010027218A1 Organische Komplexe enthaltend Metalle Organic complexes containing metals |
| 01/18/2012 | EP2407456A1 Carbazole oxime ester photoinitiator |
| 01/18/2012 | EP2407455A1 Molecular probe precursor for pancreatic islet imaging and use of same |
| 01/18/2012 | EP2407454A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
| 01/18/2012 | EP2406217A1 Tricyclic heterocyclic derivatives |
| 01/18/2012 | EP2406216A2 Halogenalkylmethylenoxy-phenyl-substituted ketoenols |
| 01/18/2012 | EP2406215A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 01/18/2012 | EP2300424B1 Use of indole derivatives as nurr-1 activators for treating parkinson s disease |
| 01/18/2012 | EP2285836B1 Photoinitiator mixtures |
| 01/18/2012 | EP1256574B1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 01/18/2012 | CN1837324B Composite materials, light emitting element and device using same |
| 01/18/2012 | CN102325753A Carbazole carboxamide compounds useful as kinase inhibitors |
| 01/18/2012 | CN102325752A Carbazole and carboline kinase inhibitors |
| 01/18/2012 | CN102325751A Aromatic amine derivative and organic electroluminescent element |
| 01/18/2012 | CN102321020A LXR receptor modulators |
| 01/18/2012 | CN102321012A Acenaphthene heterocyclic compounds and application thereof |
| 01/18/2012 | CN102321011A Method for refining cis-hexahydroisoindoline and salt thereof |
| 01/18/2012 | CN102321010A Preparation method for (2S, 3aR, 7aS)-octahydro indole-2-benzyl formate |
| 01/18/2012 | CN102321009A Arylhydrazone derivate, preparation method thereof and application in preparing anti-HIV-1 medicines |
| 01/18/2012 | CN102320908A Preparation method of beta-amino acids or derivatives of beta-amino acids |
| 01/18/2012 | CN101768118B Bi-imidazoline diphenylamine compound and preparation method thereof |
| 01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
| 01/17/2012 | US8097645 Compounds for activating TGF-β signaling |
| 01/17/2012 | US8097644 Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist |
| 01/17/2012 | US8097643 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 01/17/2012 | US8097623 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/12/2012 | WO2012006419A2 Pro-neurogenic compounds |
| 01/12/2012 | WO2012004722A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/12/2012 | WO2011133751A3 Process of producing cycloalkylcarboxamido-indole compounds |
| 01/12/2012 | WO2011116356A3 Positive allosteric modulators of group ii mglurs |
| 01/12/2012 | US20120010418 Process for Making N-Hydroxy-3[4-[[[2-(2methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and Starting Materials Therefor |
| 01/12/2012 | US20120010403 Fluoroboron compound, aminomethylating agent for aromatic ring made of the same, and production method of compound containing aminomethyl aromatic ring using aminomethylating agent |
| 01/12/2012 | US20120010263 Acetylene derivatives having mglur 5 antagonistic activity |
| 01/12/2012 | US20120010262 Crystalline polymorphic forms of an antidiabetic compound |
| 01/12/2012 | US20120010168 Unique Dual-Action Therapeutics |
| 01/12/2012 | US20120009142 Methods for treating hepatitis c |
| 01/12/2012 | US20120007063 Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics |
| 01/12/2012 | CA2805452A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/12/2012 | CA2804161A1 Pro-neurogenic compounds |
| 01/11/2012 | EP2404904A1 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 01/11/2012 | EP2403830A2 Indole derivatives for treating neurodegenerative diseases |
| 01/11/2012 | EP1994005B9 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 01/11/2012 | EP1636185B1 Novel crystalline forms of perindopril erbumine |
| 01/11/2012 | EP1569904B1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/11/2012 | CN102317261A Triple reuptake inhibitors and methods of their use |
| 01/11/2012 | CN102311544A Rosinyl plasticizer and preparation method thereof |
| 01/11/2012 | CN102311449A Application of gossypol derivative to preparing anti-tumor medicament |
| 01/11/2012 | CN102311378A Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related disorders |
| 01/11/2012 | CN102311303A Organic EL device |
| 01/11/2012 | CN102309984A Phosphoric acid amide bifunctional catalyst and synthetic method thereof |
| 01/11/2012 | CN101830854B Substituted phenylhydrazones compounds, preparation method and application thereof |
| 01/11/2012 | CN101759629B Novel preparation method for sitafloxacin intermediate |
| 01/11/2012 | CN101466671B Novel microbiocides |
| 01/11/2012 | CN101346353B Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/10/2012 | US8093411 Cyanine dyes and their applications as luminescence quenching compounds |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093386 Thioaryl substituted inhibitors of zinc proteases and their use |
| 01/10/2012 | US8093283 Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093241 Acid amide derivatives, process for their production and pesticides containing them |
| 01/10/2012 | CA2595298C Ionic liquids derived from peracid anions |
| 01/10/2012 | CA2479666C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 01/10/2012 | CA2444918C Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 01/05/2012 | WO2012002913A1 Process of forming a cyclic imide |
| 01/05/2012 | WO2012002221A1 Material for light emitting element, and light emitting element |
| 01/05/2012 | WO2012001986A1 Compound with carbazole ring structure and organic electroluminescent element |
| 01/05/2012 | WO2012001308A1 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials |
| 01/05/2012 | WO2012000421A1 Uses of gossypol derivatives in manufacture of antitumor medicaments |
| 01/05/2012 | US20120004391 Cyanine-type compounds having an alkynyl linker arm |
| 01/05/2012 | US20120004165 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120001154 Aromatic amine derivative and organic electroluminescence device using the same |
| 01/04/2012 | EP2402315A1 Oxime ester photoinitiators |
| 01/04/2012 | EP2402314A1 (Aza)indole derivative and use thereof for medical purposes |
| 01/04/2012 | EP2401254A1 Quinone compounds as dopants in organic electronics |
| 01/04/2012 | EP2265582B1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. |
| 01/04/2012 | EP1793816B1 Compositions for treating amyloid associated diseases |
| 01/04/2012 | CN102307872A BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307859A Process for the synthesis of cleistanthin |